JP2022551219A5 - - Google Patents

Info

Publication number
JP2022551219A5
JP2022551219A5 JP2022508573A JP2022508573A JP2022551219A5 JP 2022551219 A5 JP2022551219 A5 JP 2022551219A5 JP 2022508573 A JP2022508573 A JP 2022508573A JP 2022508573 A JP2022508573 A JP 2022508573A JP 2022551219 A5 JP2022551219 A5 JP 2022551219A5
Authority
JP
Japan
Prior art keywords
lentiviral
gene
promoter
mammalian cells
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022508573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551219A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/047650 external-priority patent/WO2021041322A1/en
Publication of JP2022551219A publication Critical patent/JP2022551219A/ja
Publication of JP2022551219A5 publication Critical patent/JP2022551219A5/ja
Priority to JP2025092432A priority Critical patent/JP2025148329A/ja
Pending legal-status Critical Current

Links

JP2022508573A 2019-08-23 2020-08-24 レンチウイルスベクターの製造方法および構築物 Pending JP2022551219A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025092432A JP2025148329A (ja) 2019-08-23 2025-06-03 レンチウイルスベクターの製造方法および構築物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962890904P 2019-08-23 2019-08-23
US62/890,904 2019-08-23
PCT/US2020/047650 WO2021041322A1 (en) 2019-08-23 2020-08-24 Methods and constructs for production of lentiviral vector

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025092432A Division JP2025148329A (ja) 2019-08-23 2025-06-03 レンチウイルスベクターの製造方法および構築物

Publications (2)

Publication Number Publication Date
JP2022551219A JP2022551219A (ja) 2022-12-08
JP2022551219A5 true JP2022551219A5 (enExample) 2023-08-31

Family

ID=74679320

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022508573A Pending JP2022551219A (ja) 2019-08-23 2020-08-24 レンチウイルスベクターの製造方法および構築物
JP2025092432A Pending JP2025148329A (ja) 2019-08-23 2025-06-03 レンチウイルスベクターの製造方法および構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025092432A Pending JP2025148329A (ja) 2019-08-23 2025-06-03 レンチウイルスベクターの製造方法および構築物

Country Status (7)

Country Link
US (3) US12037599B2 (enExample)
EP (1) EP4017987A4 (enExample)
JP (2) JP2022551219A (enExample)
KR (1) KR20220047635A (enExample)
CN (1) CN114286864B (enExample)
IL (1) IL290820A (enExample)
WO (1) WO2021041322A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022192193A1 (en) * 2021-03-09 2022-09-15 The Board Of Regents Of The University Of Texas System Methods and compositions for mutagenesis screening in mammalian cells
CA3217480A1 (en) * 2021-04-23 2022-10-27 Asimov Inc. Stable production systems for lentiviral vector production
KR20240099439A (ko) 2021-11-09 2024-06-28 프라운호퍼 게젤샤프트 쭈르 푀르데룽 데어 안겐반텐 포르슝 에. 베. 코알라 레트로바이러스 외피 당단백질 및 그 용도
CN121127601A (zh) * 2023-05-12 2025-12-12 隆萨生物制剂股份有限公司 使用转座酶进行混合瞬时转染以用于高产率产物生产

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7262049B2 (en) * 1999-03-16 2007-08-28 Dana-Farber Cancer Institute, Inc. Pseudotyped lentiviral vectors and uses thereof
US10087463B2 (en) 2000-10-31 2018-10-02 University Of Notre Dame Du Lac Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac
WO2002092134A1 (en) * 2001-05-14 2002-11-21 Cell Genesys, Inc. Lentiviral vectors encoding clotting factors for gene therapy
US20090042297A1 (en) * 2007-06-01 2009-02-12 George Jr Alfred L Piggybac transposon-based vectors and methods of nucleic acid integration
WO2009153563A1 (en) 2008-06-18 2009-12-23 Oxford Biomedica (Uk) Limited Virus purification
WO2011097447A2 (en) 2010-02-04 2011-08-11 Neurologix, Inc. Production of recombinant virus
WO2012028681A1 (en) 2010-09-02 2012-03-08 Molmed Spa Stable production of lentiviral vectors
CA2776577C (en) 2010-10-05 2021-03-30 Bayer Cropscience Lp A system and method establishing an agricultural pedigree for at least one agricultural product
WO2013076309A1 (en) 2011-11-24 2013-05-30 Genethon Scalable lentiviral vector production system compatible with industrial pharmaceutical applications
PT2790737T (pt) 2011-12-12 2019-02-28 Childrens Hospital Philadelphia Sistema de produção de vetores lentivirais a grande escala comercial e vetores produzidos pelo mesmo
PT2970920T (pt) 2013-03-15 2018-07-30 Childrens Hospital Philadelphia Processo de fabrico escalável para produzir vetores lentivirais recombinantes em sistema de cultura de células de suspensão livres de soro
FR3010720B1 (fr) 2013-09-16 2017-08-11 Genethon Procede de production de virus enveloppes
FR3014901B1 (fr) 2013-12-17 2017-06-09 Genethon Procede de purification de virus ou vecteurs viraux enveloppes
GB201417042D0 (en) 2014-09-29 2014-11-12 Fkd Therapies Oy Method
US20160267432A1 (en) 2015-03-13 2016-09-15 GeoPRI, LLC Systems and methods for tracking an individual unit
US20160350715A1 (en) 2015-05-29 2016-12-01 Eugenio Minvielle Nutrition Based Food System and Method
FR3044016A1 (fr) * 2015-11-24 2017-05-26 Glaxosmithkline Ip Dev Ltd Lignees cellulaires stables pour la production retrovirale
GB201603372D0 (en) * 2016-02-26 2016-04-13 Ucl Business Plc Cell
GB201603374D0 (en) * 2016-02-26 2016-04-13 Ucl Business Plc Packaging cell
US10699284B2 (en) 2016-08-10 2020-06-30 Label Insight, Inc. Information management system for product ingredients to fill gaps in the market and to determine proper attribution
GB201705927D0 (en) 2017-04-12 2017-05-24 Oxford Genetics Ltd Vector
GB201715052D0 (en) 2017-09-19 2017-11-01 Oxford Genetics Ltd Vectors
EP3456822A1 (en) 2017-09-19 2019-03-20 CEVEC Pharmaceuticals GmbH Inducible aav rep genes
JP7598864B2 (ja) 2018-12-21 2024-12-12 ロンザ ウォーカーズヴィル，インコーポレーテッド ウイルスベクターの自動産生方法

Similar Documents

Publication Publication Date Title
JP7105875B2 (ja) レトロウイルスベクター
JP2018534937A5 (enExample)
JP2022514761A5 (enExample)
RU2018122636A (ru) Стабильные клеточные линии для продуцирования ретровирусов
PH12019502774A1 (en) ENHANCING AGENTS FOR IMPROVED CELL TRANSFECTION AND/OR rAAV VECTOR PRODUCTION
CA2456169A1 (en) Methods and compositions relating to improved lentiviral vector production systems
FI3633040T3 (fi) Retrovirusvektori
JP7672114B2 (ja) 安定したレンチウイルスパッケージング細胞株およびその作成方法
JP2019500030A5 (enExample)
US20240167055A1 (en) Compositions and methods for producing and characterizing viral vector producer cells for cell and gene therapy
RU2018118964A (ru) Способ временной трансфекции для продуцирования ретровируса
Aurélie et al. Lentiviral vectors: a powerful tool to target astrocytes in vivo
CN105331635A (zh) 一种诱导型慢病毒表达体系及其构建方法和应用
Santhosh et al. A lentiviral vector with novel multiple cloning sites: stable transgene expression in vitro and in vivo
CN103492577B (zh) 用于动物细胞的表达载体
JP2024529015A5 (enExample)
CN105695494A (zh) 一种三顺反子表达载体、制备方法及应用
WO2023050158A1 (zh) 一种实现多碱基编辑的方法
JP2024520797A5 (enExample)
WO2015182941A9 (ko) 신규 카탈라아제 신호서열 및 이를 이용한 카탈라아제 발현방법
CN104561005B (zh) 一种用于对虾细胞的启动子
JP2024514961A5 (enExample)
Mursi et al. The production of recombinant proteins from mammalian cells using RNA element
CN109468323B (zh) 人工合成的内含子、哺乳动物细胞重组表达载体、哺乳动物宿主细胞、表达方法及其应用
CN120924500A (zh) 高产慢病毒的细胞系及其制备方法